{"id":"https://openalex.org/W2006283117","doi":"https://doi.org/10.1002/mds.870130208","title":"Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6\u2010hydroxydopamine","display_name":"Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6\u2010hydroxydopamine","alternate_titles":[],"publication_year":1998,"publication_date":"1998-03-01","ids":{"openalex":"https://openalex.org/W2006283117","doi":"https://doi.org/10.1002/mds.870130208","mag":"2006283117","pmid":"https://pubmed.ncbi.nlm.nih.gov/9539336"},"language":"en","primary_location":{"id":"doi:10.1002/mds.870130208","doi":"https://doi.org/10.1002/mds.870130208","is_oa":false,"landing_page_url":"https://doi.org/10.1002/mds.870130208","pdf_url":null,"source":{"id":"https://openalex.org/S163027424","display_name":"Movement Disorders","issn_l":"0885-3185","issn":["0885-3185","1531-8257"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Movement Disorders","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2006283117"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001860395","display_name":"Michael Gassen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]},{"id":"https://openalex.org/I4210117163","display_name":"Rappaport Family Institute for Research in the Medical Sciences","ror":"https://ror.org/029hzjx43","country_code":"IL","type":"facility","lineage":["https://openalex.org/I4210117163"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Gassen","raw_affiliation_strings":["Department of Pharmacology, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion, Haifa, Israel","Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Disease, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion, Haifa, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion, Haifa, Israel","institution_ids":["https://openalex.org/I174306211"]},{"raw_affiliation_string":"Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Disease, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion, Haifa, Israel","institution_ids":["https://openalex.org/I174306211","https://openalex.org/I4210117163"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002662701","display_name":"Aviva Gross","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]},{"id":"https://openalex.org/I4210117163","display_name":"Rappaport Family Institute for Research in the Medical Sciences","ror":"https://ror.org/029hzjx43","country_code":"IL","type":"facility","lineage":["https://openalex.org/I4210117163"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aviva Gross","raw_affiliation_strings":["Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Disease, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion, Haifa, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Disease, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion, Haifa, Israel","institution_ids":["https://openalex.org/I174306211","https://openalex.org/I4210117163"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053858269","display_name":"Moussa B. H. Youdim","orcid":"https://orcid.org/0000-0002-1361-3872","observed_orcids":["https://orcid.org/0000-0002-1361-3872"]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]},{"id":"https://openalex.org/I4210117163","display_name":"Rappaport Family Institute for Research in the Medical Sciences","ror":"https://ror.org/029hzjx43","country_code":"IL","type":"facility","lineage":["https://openalex.org/I4210117163"]}],"countries":["IL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Moussa B. H. Youdim","raw_affiliation_strings":["Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Disease, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion, Haifa, Israel","Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Diseases, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion, Haifa, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Disease, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion, Haifa, Israel","institution_ids":["https://openalex.org/I174306211","https://openalex.org/I4210117163"]},{"raw_affiliation_string":"Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Diseases, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion, Haifa, Israel","institution_ids":["https://openalex.org/I174306211","https://openalex.org/I4210117163"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5053858269"],"corresponding_institution_ids":["https://openalex.org/I174306211","https://openalex.org/I4210117163"],"apc_list":{"value":4480,"currency":"USD","value_usd":4480},"apc_paid":null,"fwci":7.708,"has_fulltext":false,"cited_by_count":135,"citation_normalized_percentile":{"value":0.97727153,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"13","issue":"2","first_page":"242","last_page":"248"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apomorphine","display_name":"apomorphine","score":0.9750000238418579},{"id":"https://openalex.org/keywords/enantiomers","display_name":"enantiomers","score":0.9039999842643738},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.7770000100135803},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.968999981880188},{"id":"https://openalex.org/keywords/hydrogen-peroxide","display_name":"hydrogen peroxide","score":0.7990000247955322},{"id":"https://openalex.org/keywords/6-hydroxydopamine","display_name":"6-hydroxydopamine","score":1.0},{"id":"https://openalex.org/keywords/pc12-cells","display_name":"PC12 cells","score":0.9409999847412109},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.8669999837875366},{"id":"https://openalex.org/keywords/dopaminergic-neurons","display_name":"dopaminergic neurons","score":0.7710000276565552},{"id":"https://openalex.org/keywords/antioxidant-activity","display_name":"antioxidant activity","score":0.7919999957084656},{"id":"https://openalex.org/keywords/pergolide","display_name":"pergolide","score":0.875}],"concepts":[{"id":"https://openalex.org/C2911016594","wikidata":"https://www.wikidata.org/wiki/Q15946111","display_name":"Hydroxydopamine","level":4,"score":0.8982925415039062},{"id":"https://openalex.org/C2777525119","wikidata":"https://www.wikidata.org/wiki/Q269111","display_name":"Apomorphine","level":4,"score":0.8542091250419617},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.6933492422103882},{"id":"https://openalex.org/C486523","wikidata":"https://www.wikidata.org/wiki/Q494483","display_name":"Enantiomer","level":2,"score":0.5861249566078186},{"id":"https://openalex.org/C57600042","wikidata":"https://www.wikidata.org/wiki/Q227564","display_name":"Oxidative phosphorylation","level":2,"score":0.42886608839035034},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.42178672552108765},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.42154601216316223},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39154160022735596},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3443275988101959},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.23816168308258057},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.23579731583595276},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1587246060371399},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.0853029191493988}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001058","descriptor_name":"Apomorphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006861","descriptor_name":"Hydrogen Peroxide","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D009498","descriptor_name":"Neurotoxins","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015227","descriptor_name":"Lipid Peroxidation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016627","descriptor_name":"Oxidopamine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D016716","descriptor_name":"PC12 Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016877","descriptor_name":"Oxidants","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D017382","descriptor_name":"Reactive Oxygen Species","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018384","descriptor_name":"Oxidative Stress","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/mds.870130208","doi":"https://doi.org/10.1002/mds.870130208","is_oa":false,"landing_page_url":"https://doi.org/10.1002/mds.870130208","pdf_url":null,"source":{"id":"https://openalex.org/S163027424","display_name":"Movement Disorders","issn_l":"0885-3185","issn":["0885-3185","1531-8257"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Movement Disorders","raw_type":"journal-article"},{"id":"pmid:9539336","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9539336","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Movement disorders : official journal of the Movement Disorder Society","raw_type":"Journal Article"},{"id":"pmid:9686771","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9686771","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Movement disorders : official journal of the Movement Disorder Society","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W45938194","https://openalex.org/W993271046","https://openalex.org/W1963932280","https://openalex.org/W1964230438","https://openalex.org/W1969291345","https://openalex.org/W1989277130","https://openalex.org/W1993736002","https://openalex.org/W1998750126","https://openalex.org/W2005754114","https://openalex.org/W2006688912","https://openalex.org/W2010394776","https://openalex.org/W2016302324","https://openalex.org/W2023729075","https://openalex.org/W2040545684","https://openalex.org/W2050531538","https://openalex.org/W2052506116","https://openalex.org/W2065700794","https://openalex.org/W2066908355","https://openalex.org/W2071866216","https://openalex.org/W2079806597","https://openalex.org/W2093708814","https://openalex.org/W2095378987","https://openalex.org/W2117665761","https://openalex.org/W2133451731","https://openalex.org/W2164284326","https://openalex.org/W2424850491","https://openalex.org/W2606051482"],"related_works":["https://openalex.org/W1497540774","https://openalex.org/W2226922866","https://openalex.org/W2015902047","https://openalex.org/W2066908355","https://openalex.org/W2091217976","https://openalex.org/W8865524","https://openalex.org/W1980841128","https://openalex.org/W61725528","https://openalex.org/W2081798195","https://openalex.org/W2028805066"],"abstract_inverted_index":{"A":[0],"significant":[1],"body":[2],"of":[3,21,42,72,83,110,125],"evidence":[4],"has":[5,45],"been":[6,46],"provided":[7],"to":[8,48,54],"support":[9],"the":[10,19,25,39,80,88,126,130],"hypothesis":[11],"that":[12,69,133,150],"oxidant":[13],"stress":[14],"may":[15,148],"be":[16,49,143],"responsible":[17],"for":[18],"degeneration":[20],"dopaminergic":[22],"neurons":[23],"in":[24,30,38,59],"substantia":[26],"nigra":[27],"pars":[28],"compacta":[29],"Parkinson's":[31,43],"disease.":[32],"Apomorphine,":[33],"a":[34,50,154],"dopamine":[35],"D1/D2-receptor":[36],"agonist":[37],"clinical":[40,131],"therapy":[41],"disease,":[44],"found":[47],"potent":[51,120,159],"antioxidant":[52,160],"and":[53,87,129,141],"prevent":[55],"free":[56],"radical":[57],"reaction":[58],"rat":[60,75],"brain":[61],"mitochondrial":[62],"fraction.":[63],"In":[64,123],"this":[65],"article":[66],"we":[67],"show":[68],"1-10":[70],"microM":[71],"apomorphine":[73,138,151],"protects":[74],"pheochromocytoma":[76],"(PC12)":[77],"cells":[78,112],"from":[79],"toxic":[81],"effects":[82,94],"H2O2":[84,114],"(0.6":[85],"mM)":[86],"neurotoxin":[89],"6-hydroxydopamine":[90],"(150":[91],"microM).":[92],"These":[93],"were":[95],"not":[96,118],"exhibited":[97,107],"by":[98],"ascorbic":[99],"acid,":[100],"desferal,":[101],"lisuride,":[102],"or":[103],"bromocriptine.":[104],"Although":[105],"pergolide":[106],"some":[108],"protection":[109],"PC12":[111],"against":[113],"toxicity,":[115],"it":[116],"was":[117],"as":[119,121],"apomorphine.":[122],"light":[124],"present":[127],"findings":[128],"reports":[132],"parkinsonian":[134],"patients":[135],"on":[136],"long-term":[137],"stabilize":[139],"clinically":[140],"can":[142,152],"weaned":[144],"off":[145],"L-dopa,":[146],"one":[147],"assume":[149],"exert":[153],"neuroprotective":[155],"activity":[156],"via":[157],"its":[158],"properties.":[161]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2006283117","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
